Literature DB >> 2656985

Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.

M Mishima1, S Okada, Y Wakita, M Nakano.   

Abstract

Nasal absorption of insulin in rats was enhanced by addition of sodium glycyrrhetinate (GA Na), dipotassium glycyrrhizinate (GZ K2), and carbenoxolone (glycyrrhetinic acid hydrogen succinate) disodium salt (GAHS Na2). The latter agent was the most effective. On addition of 1% GAHS Na2, plasma immunoreactive insulin levels in rats showed a maximum level of 0.75 mU/ml at 15 min and plasma glucose levels were decreased to about 25 mg/dl after nasal administration of 10 U/kg insulin. In a comparison of the absorption rates of insulin by nasal and intravenous (i.v.) routes in rats, nasal absorptions of 10 U/kg insulin in the presence of 1% GAHS Na2, 0.5% GA Na and 1% GZ K2 were 26.5%, 13.2% and 14.5% of that in the case of a 5 U/kg i.v. dose, respectively. Hemolytic activies of GAHS Na2, GA Na and GZ K2 were milder than those of Na caprate and Na laurate, and nasal leucine aminopeptidase activity was more strongly inhibited by GAHS Na2 than by medium chain fatty acid salts, sodium glycocholate, GA Na or GZ K2. Therefore, it is suggested that GAHS Na2 is a very useful promoter which dose not irritate the nasal mucosal membrane or degrade insulin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656985     DOI: 10.1248/bpb1978.12.31

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  8 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.

Authors:  J Recchia; M H Lurantos; J A Amsden; J Storey; C R Kensil
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

Review 3.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  Drug Dev Res       Date:  2006-02       Impact factor: 4.360

5.  In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol, and lucifer yellow.

Authors:  P M Reardon; C H Gochoco; K L Audus; G Wilson; P L Smith
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

6.  Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro.

Authors:  P M Reardon; D A Wall; T K Hart; P L Smith; C H Gochoco
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

7.  In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.

Authors:  T Imai; M Sakai; H Ohtake; H Azuma; M Otagiri
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

8.  Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System.

Authors:  Hiraku Onishi; Ayako Tokuyasu
Journal:  Int J Mol Sci       Date:  2016-09-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.